{
  "name": "Prescribing of gabapentin and pregabalin (DDD)",
  "title": [
    "Prescribing of gabapentin and pregabalin (combined Defined Daily Dose (DDD) per 1000 patients"
  ],
  "description": [
    "Total DDD of pregabalin + gabapentin per 1000 patients"
  ],
  "why_it_matters": [
    "Gabapentin and pregabalin are increasingly used in neuropathic and other types of pain, and use is ",
    "rising rapidly in the NHS. There are also concerns about the ",
    "<a href='https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/385791/PHE-NHS_England_pregabalin_and_gabapentin_advice_Dec_2014.pdf'>",
    "potential for abuse</a> and consequently both medicines have been reclassified legally  <a href='https://www.england.nhs.uk/wp-content/uploads/2019/03/pregabalin-and-gabapentin-guidance-v1.pdf'> (more information here)</a>. There appears to be no robust evidence for dose conversion between gabapentin and pregabalin. ",
     "We have therefore chosen to use the <a href='https://www.who.int/medicines/regulation/medicines-safety/toolkit_ddd/en/'>",
    "Defined Daily Dose</a> (DDD) for this measure.  This is a similar dose ratio that <a href='https://www.ncbi.nlm.nih.gov/pubmed/20113408'>",
    "Toth described</a> in his paper on the substitution of gabapentin with pregabalin. ",
    "<br><br><strong>Please note that this is an experimental measure.</strong> We would be grateful for any feedback at ",
    "<a href='mailto:hello@ebmdatalab.net'>hello@ebmdatalab.net.</a>"
  ],
  "numerator_short": "Gabapentin total DDD prescribed + pregabalin total DDD prescribed",
  "denominator_short": "1000 patients",
  "url": null,
  "is_percentage": false,
  "is_cost_based": false,
  "low_is_good": null,
  "tags": [
    "core",
    "pain",
    "safety"
  ],
  "numerator_type": "custom",
  "numerator_columns": [
    "SUM((p.quantity * r.strnt)/CASE WHEN p.bnf_code LIKE '0408010AE%' THEN 300 ELSE 1800 END) AS numerator--divide by 300 (pregab) or 1800 (gaba) to get DDD "
  ],
 "numerator_from": "{hscic}.normalised_prescribing_standard p  FULL JOIN {measures}.dmd_unit_dose_strength_missing_fix f   CONCAT(SUBSTR(p.bnf_code,0,9), SUBSTR(p.bnf_code,-2)) = concat(SUBSTR(f.original_bnf_code,0,9), SUBSTR(f.original_bnf_code,-2)) LEFT JOIN {measures}.dmd_unit_dose_strength r ON CONCAT(COALESCE(SUBSTR(f.match_bnf_code,0,9),SUBSTR(p.bnf_code,0,9)),COALESCE(SUBSTR(f.match_bnf_code,-2),SUBSTR(p.bnf_code,-2))) = CONCAT(SUBSTR(r.bnf_code,0,9),SUBSTR(r.bnf_code,-2))",
  "numerator_where": [
    "  substr(p.bnf_code,0,9) IN ('0408010AE','0408010G0') AND r.ing IN (415160008,386845007)--Pregabalin  and gabapentin (bnf_code and ing code)"
  ],
   "numerator_bnf_codes_query": "SELECT DISTINCT presentation_code FROM {hscic}.bnf WHERE presentation_code LIKE '0408010AE%' or presentation_code LIKE '0408010G0%'",
  "denominator_type": "list_size",
   "date_reviewed": [
    "2019-10-16"
  ],
  "next_review": [
    "2020-10-16"
  ],
  "authored_by": [
    "richard.croker@phc.ox.ac.uk"
  ],
  "checked_by": [
    " "
  ],
  "measure_complexity": [
    "low"
 ]
}
